93.48
-0.02(-0.02%)
Currency In USD
| Previous Close | 93.5 |
| Open | 94.18 |
| Day High | 94.41 |
| Day Low | 92.85 |
| 52-Week High | 111.45 |
| 52-Week Low | 82.62 |
| Volume | 578,511 |
| Average Volume | 703,562 |
| Market Cap | 5.52B |
| PE | 45.82 |
| EPS | 2.04 |
| Moving Average 50 Days | 94.53 |
| Moving Average 200 Days | 99.12 |
| Change | -0.02 |
If you invested $1000 in Merit Medical Systems, Inc. (MMSI) 10 years ago, it would be worth $4,366.18 as of July 01, 2025 at a share price of $93.48. Whereas If you bought $1000 worth of Merit Medical Systems, Inc. (MMSI) shares 5 years ago, it would be worth $2,067.68 as of July 01, 2025 at a share price of $93.48.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
GlobeNewswire Inc.
May 06, 2025 1:25 PM GMT
The WRAPSODY CIE is designed to help physicians prolong functional vascular access in hemodialysis patients.Approval was supported by superior 12-month target lesion primary patency (70.1%) and access circuit primary patency (58.1%) in the randomized
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
GlobeNewswire Inc.
May 05, 2025 1:25 PM GMT
In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months.SOUTH JORDAN, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (N
Merit Medical Launches the Ventrax™ Delivery System
GlobeNewswire Inc.
Apr 09, 2025 1:25 PM GMT
Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardiaSOUTH JORDAN, Utah, April 09, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare tech